Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

TLXTLX
4 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in TELIX PHARMACEUTICAL LTD

Yes. JPMorgan Chase holds 77,538 shares of TLX (Telix Pharmaceutical), worth $876,185, as of its Q2 2026 13F filing. It increased the position by 20,190 shares (+35.2%) from Q1 2026. JPMorgan Chase has held TLX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$876,185

Current Shares

77,538

Total Value Change

+$633,538

Total Shares Change

+52,183

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
77,538
+35.2%
$876,1850.0%$11.53
22
2026-Q1
Decreased
57,348
-22.9%
$513,8380.0%$6.97
0
2025-Q4
Increased
74,368
+193.3%
$557,0160.0%$7.75
27
2025-Q3
New
25,355
-
$242,6470.0%$9.89
35

Other major holders of TLX: FMR LLC, LAZARD ASSET MANAGEMENT LLC, Private Advisor Group, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used